Last 7 days
-3.9%
Last 30 days
-14.8%
Last 90 days
-7.6%
Trailing 12 Months
2.2%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-03 | DENKHAUS DONALD A | acquired | 67,800 | 1.13 | 60,000 | - |
2023-06-27 | Del Carmen Jeffrey | acquired | - | - | 10,000 | chief commercial officer |
2023-06-27 | Del Carmen Jeffrey | sold (taxes) | - | - | -3,942 | chief commercial officer |
2023-05-16 | MCENANY PATRICK J | acquired | 137,341 | 0.79 | 173,849 | president and ceo |
2023-05-15 | MCENANY PATRICK J | sold | -345,978 | 13.23 | -26,151 | president and ceo |
2023-05-15 | MCENANY PATRICK J | acquired | 20,659 | 0.79 | 26,151 | president and ceo |
2023-05-12 | Daly Richard J | acquired | 39,500 | 0.79 | 50,000 | - |
2023-05-11 | Tierney David S | acquired | 15,800 | 0.79 | 20,000 | - |
2023-05-11 | Miller Steve | acquired | 79,000 | 0.79 | 100,000 | chief operating officer |
2023-05-04 | COELHO PHILIP H | acquired | 39,500 | 0.79 | 50,000 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 241 | 5,693,000 | 8,907,000 | 0.01% |
2023-09-12 | Farther Finance Advisors, LLC | unchanged | - | -1,783 | 7,634 | -% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | reduced | -55.56 | -4,773 | 2,688 | -% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -312,056 | 1,335,680 | 0.01% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 50.9 | 165,044 | 904,512 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.08 | -420,392 | 1,618,140 | -% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 5.57 | -71,000 | 423,000 | -% |
2023-08-21 | VisionPoint Advisory Group, LLC | new | - | 42,685 | 42,685 | 0.02% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -23.23 | -292,951 | 482,550 | -% |
2023-08-17 | Orion Portfolio Solutions, LLC | added | 29.6 | 8,934 | 185,660 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | armistice capital, llc | 0% | 0 | SC 13G/A | |
Feb 10, 2023 | flynn james e | 5.65% | 5,884,448 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 6.50% | 6,768,741 | SC 13G | |
Feb 08, 2023 | state street corp | 7.57% | 7,873,314 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 15.1% | 15,690,326 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 15.1% | 15,690,326 | SC 13G/A | |
Nov 14, 2022 | flynn james e | 5.82% | 6,060,491 | SC 13G | |
Feb 15, 2022 | armistice capital, llc | 9.3% | 9,572,000 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 4.69% | 4,836,313 | SC 13G/A | |
Feb 09, 2022 | state street corp | 4.90% | 5,050,989 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 08, 2023 | S-3ASR | S-3ASR | |
Aug 25, 2023 | 8-K | Current Report | |
Aug 09, 2023 | 8-K | Current Report | |
Aug 09, 2023 | 10-Q | Quarterly Report | |
Aug 04, 2023 | 4 | Insider Trading | |
Jul 28, 2023 | 8-K | Current Report | |
Jul 21, 2023 | 8-K | Current Report | |
Jul 17, 2023 | ARS | ARS | |
Jul 12, 2023 | DEF 14A | DEF 14A | |
Jun 29, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 272.0B | 56.0B | 5.43% | 9.20% | 31.31 | 4.85 | -2.31% | -31.27% |
BGNE | 255.4B | 1.8B | -4.05% | 37.32% | -147.41 | 141.03 | 69.45% | 14.65% |
VRTX | 90.7B | 9.5B | 0.17% | 23.71% | 26.94 | 9.54 | 13.83% | 5.33% |
REGN | 89.1B | 12.7B | 0.52% | 19.69% | 20.72 | 7.03 | -10.94% | -24.40% |
ALNY | 21.9B | 1.2B | -9.77% | -14.95% | -20.56 | 17.67 | 39.94% | -8.44% |
SRPT | 11.1B | 1.0B | -3.58% | 6.05% | -12.27 | 11.1 | 20.15% | -79.16% |
UTHR | 10.8B | 2.1B | -2.16% | 7.92% | 12.38 | 5.11 | 18.01% | 38.16% |
MID-CAP | ||||||||
BPMC | 3.0B | 225.6M | -2.45% | -24.77% | -5.46 | 13.42 | -2.11% | 21.02% |
MDGL | 2.8B | - | -15.83% | 131.72% | -8.45 | - | - | -28.88% |
RARE | 2.6B | 402.9M | -3.27% | -11.64% | -3.64 | 6.51 | 20.50% | -42.46% |
MRTX | 2.4B | 27.2M | 11.70% | -39.35% | -3.27 | 88.62 | - | -14.43% |
SMALL-CAP | ||||||||
CYTK | 3.1B | - | -14.00% | -40.97% | -7.31 | 33.28 | 34.30% | -149.91% |
CPRX | 1.3B | 302.9M | -14.82% | 2.19% | 11.19 | 4.27 | 77.72% | 112.02% |
MGNX | 284.9M | 152.5M | -8.91% | 51.32% | 38.25 | 1.87 | 127.84% | 103.41% |
CRBP | 28.4M | - | -10.88% | 3445.93% | -0.62 | - | - | -31.51% |
14.2%
39.7%
26.7%
56.6%
90.8%
67.7%
63.1%
Y-axis is the maximum loss one would have experienced if Catalyst Pharmaceuticals was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2010Q4 |
Revenue | 18.1% | 303 | 256 | 214 | 192 | 170 | 154 | 141 | 134 | 127 | 120 | 119 | 118 | 120 | 119 | 102 | 73.00 | 56.00 | 26.00 | 2.00 | 0.00 |
Operating Expenses | 20.8% | 165 | 136 | 112 | 108 | 98.00 | 94.00 | 88.00 | 84.00 | 82.00 | 82.00 | 78.00 | - | - | - | - | - | 55.00 | 43.00 | 36.00 | - |
S&GA Expenses | 21.7% | 87.00 | 71.00 | 58.00 | 57.00 | 55.00 | 53.00 | 50.00 | 50.00 | 48.00 | 47.00 | 44.00 | 42.00 | 40.00 | 39.00 | 37.00 | 32.00 | 28.00 | 22.00 | 16.00 | - |
R&D Expenses | -0.1% | 20.00 | 20.00 | 20.00 | 21.00 | 17.00 | 17.00 | 17.00 | 16.00 | 15.00 | 15.00 | 16.00 | 19.00 | 19.00 | 20.00 | 19.00 | 21.00 | 21.00 | 20.00 | 20.00 | - |
EBITDA | -100.0% | - | 125 | 105 | 85.00 | 73.00 | 60.00 | 53.00 | 49.00 | 46.00 | 41.00 | 42.00 | 42.00 | 44.00 | 45.00 | 33.00 | 11.00 | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.49* | 0.49* | 0.44* | 0.43* | 0.39* | 0.38* | 0.37* | 0.37* | 0.34* | 0.35* | 0.35* | 0.37* | 0.38* | 0.33* | 0.14* | - | - | - | - |
Earnings Before Taxes | 16.3% | 145 | 125 | 105 | 85.00 | 73.00 | 60.00 | 53.00 | 49.00 | 46.00 | 41.00 | 42.00 | 42.00 | 44.00 | 45.00 | 33.00 | 11.00 | -11.57 | -28.95 | -34.00 | - |
EBT Margin | -100.0% | - | 0.49* | 0.49* | 0.44* | 0.43* | 0.39* | 0.37* | 0.36* | 0.36* | 0.34* | 0.35* | 0.35* | 0.37* | 0.38* | 0.33* | 0.14* | - | - | - | - |
Net Income | 16.2% | 116 | 99.00 | 83.00 | 67.00 | 54.00 | 45.00 | 39.00 | 42.00 | 75.00 | 72.00 | 75.00 | 71.00 | 42.00 | 43.00 | 32.00 | 9.00 | -12.02 | -28.95 | -34.00 | - |
Net Income Margin | -100.0% | - | 0.39* | 0.39* | 0.35* | 0.32* | 0.29* | 0.28* | 0.31* | 0.59* | 0.60* | 0.63* | 0.60* | 0.35* | 0.36* | 0.31* | 0.13* | - | - | - | - |
Free Cashflow | -100.0% | - | 120 | 116 | 95.00 | 75.00 | 64.00 | 59.00 | 53.00 | 43.00 | 40.00 | 45.00 | 44.00 | 49.00 | 50.00 | 35.00 | 14.00 | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 9.0% | 444 | 407 | 376 | 333 | 267 | 247 | 238 | 223 | 209 | 197 | 192 | 175 | 131 | 118 | 112 | 97.00 | 78.00 | 61.00 | 60.00 | 68.00 | 74.00 |
Current Assets | 21.1% | 241 | 199 | 321 | 276 | 243 | 221 | 210 | 193 | 176 | 162 | 159 | 143 | 131 | 117 | 111 | 91.00 | 72.00 | 55.00 | 55.00 | 62.00 | 69.00 |
Cash Equivalents | 20.6% | 179 | 148 | 298 | 256 | 211 | 178 | 171 | 155 | 135 | 127 | 130 | 117 | 115 | 102 | 90.00 | 45.00 | 23.00 | 19.00 | 17.00 | 11.00 | 10.00 |
Inventory | 4.1% | 11.00 | 10.00 | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 7.00 | 7.00 | 4.00 | 5.00 | 5.00 | 2.00 | 2.00 | 2.00 | 1.00 | 0.00 | 0.00 | 0.00 | - | - |
Net PPE | -6.4% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | -6.7% | 69.00 | 74.00 | 75.00 | 63.00 | 26.00 | 27.00 | 31.00 | 25.00 | 20.00 | 19.00 | 23.00 | 18.00 | 20.00 | 18.00 | 25.00 | 19.00 | 15.00 | 10.00 | 10.00 | 4.00 | 3.00 |
Current Liabilities | -7.4% | 53.00 | 57.00 | 58.00 | 45.00 | 22.00 | 23.00 | 27.00 | 21.00 | 16.00 | 14.00 | 23.00 | 18.00 | 20.00 | 18.00 | 24.00 | 18.00 | 14.00 | 9.00 | 10.00 | 3.00 | 3.00 |
Shareholder's Equity | 12.5% | 375 | 334 | 300 | 270 | 241 | 220 | 207 | 199 | 189 | 179 | 170 | 157 | 111 | 100 | 88.00 | 78.00 | 63.00 | 51.00 | 51.00 | 64.00 | 71.00 |
Retained Earnings | 47.5% | 117 | 79.00 | 50.00 | 24.00 | 2.00 | -15.62 | -26.31 | -32.54 | -37.82 | -46.33 | -53.70 | -65.14 | -108 | -118 | -128 | -136 | -150 | -161 | -160 | -146 | -138 |
Additional Paid-In Capital | 1.5% | 258 | 254 | 250 | 246 | 239 | 236 | 233 | 231 | 227 | 225 | 223 | 222 | 220 | 218 | 216 | 214 | 213 | 212 | 211 | 210 | 209 |
Shares Outstanding | 0.5% | 107 | 106 | 105 | 104 | 103 | 103 | 103 | 103 | 103 | 104 | 104 | 104 | 103 | 103 | 103 | 103 | 103 | 103 | 103 | 103 | 103 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 3.8% | 124 | 120 | 116 | 95.00 | 76.00 | 65.00 | 60.00 | 54.00 | 44.00 | 42.00 | 45.00 | 44.00 | 49.00 | 50.00 | 35.00 | 14.00 | -9.25 | -28.08 | -26.15 | -21.83 | -17.51 |
Share Based Compensation | 14.3% | 10.00 | 9.00 | 8.00 | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 |
Cashflow From Investing | 25.0% | -162 | -216 | 9.00 | -0.35 | -0.22 | - | -11.02 | -10.98 | -20.92 | -16.92 | -5.01 | 27.00 | 42.00 | 32.00 | 37.00 | 20.00 | 22.00 | 27.00 | -15.08 | -29.17 | -36.77 |
Cashflow From Financing | 81.9% | 6.00 | 3.00 | 2.00 | -3.08 | -9.17 | -9.88 | -8.14 | -5.59 | -2.88 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 54.00 | 56.00 |
Buy Backs | -100.0% | - | 4.00 | 7.00 | 10.00 | 15.00 | 14.00 | 12.00 | 12.00 | 8.00 | 1.00 | - | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |||
Revenues: | ||||||
Total revenues | $ 99,582 | $ 53,113 | $ 184,948 | $ 96,202 | ||
Operating costs and expenses: | ||||||
Cost of sales | [1] | 12,045 | 7,643 | 21,991 | 13,533 | |
Research and development | 3,954 | 3,983 | 7,516 | 7,386 | ||
Selling, general and administrative | [1] | 28,396 | 12,918 | 58,114 | 29,348 | |
Amortization of intangible assets | 8,488 | 0 | 15,019 | 0 | ||
Total operating costs and expenses | 52,883 | 24,544 | 102,640 | 50,267 | ||
Operating income | 46,699 | 28,569 | 82,308 | 45,935 | ||
Other income (expense), net | 1,813 | (324) | 3,517 | (231) | ||
Net income before income taxes | 48,512 | 28,245 | 85,825 | 45,704 | ||
Income tax provision | 10,750 | 6,626 | 18,495 | 10,844 | ||
Net income | $ 37,762 | $ 21,619 | $ 67,330 | $ 34,860 | ||
Net income per share: | ||||||
Basic | $ 0.36 | $ 0.21 | $ 0.64 | $ 0.34 | ||
Diluted | $ 0.33 | $ 0.2 | $ 0.59 | $ 0.32 | ||
Weighted average shares outstanding: | ||||||
Basic | 106,258,790 | 102,795,600 | 105,911,936 | 102,788,719 | ||
Diluted | 113,673,534 | 109,264,730 | 113,840,155 | 109,149,185 | ||
Net income | $ 37,762 | $ 21,619 | $ 67,330 | $ 34,860 | ||
Other comprehensive income (Note 4): | ||||||
Unrealized gain (loss) on available-for-sale securities, net of tax of ($3), ($101), $2 and $2, respectively | 8 | 323 | (5) | 18 | ||
Comprehensive income | 37,770 | 21,942 | 67,325 | 34,878 | ||
Product revenue, net [Member] | ||||||
Revenues: | ||||||
Total revenues | 99,477 | 53,049 | 184,781 | 96,082 | ||
License and other revenue [Member] | ||||||
Revenues: | ||||||
Total revenues | $ 105 | $ 64 | $ 167 | $ 120 | ||
|
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 178,787 | $ 298,395 |
Accounts receivable, net | 42,796 | 10,439 |
Inventory | 10,751 | 6,805 |
Prepaid expenses and other current assets | 8,634 | 5,167 |
Total current assets | 240,968 | 320,806 |
Operating lease right-of-use asset | 2,641 | 2,770 |
Property and equipment, net | 1,203 | 847 |
License and acquired intangibles, net | 175,595 | 32,471 |
Deferred tax assets, net | 23,489 | 18,736 |
Total assets | 443,896 | 375,630 |
Current Liabilities: | ||
Accounts payable | 4,421 | 3,975 |
Accrued expenses and other liabilities | 48,082 | 53,613 |
Total current liabilities | 52,503 | 57,588 |
Operating lease liability, net of current portion | 3,376 | 3,557 |
Other non-current liabilities | 12,723 | 14,064 |
Total liabilities | 68,602 | 75,209 |
Commitments and contingencies (Note 12) | ||
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 5,000,000 shares authorized: none issued and outstanding at June 30, 2023 and December 31, 2022 | 0 | 0 |
Common stock, $0.001 par value, 200,000,000 shares authorized; 106,501,259 shares and 105,263,031 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 107 | 105 |
Additional paid-in capital | 257,976 | 250,430 |
Retained earnings | 117,192 | 49,862 |
Accumulated other comprehensive income (loss) (Note 4) | 19 | 24 |
Total stockholders' equity | 375,294 | 300,421 |
Total liabilities and stockholders' equity | $ 443,896 | $ 375,630 |